{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:41:39Z","timestamp":1792798899407,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To provide an objective characterization of acute neurologic injury in critically ill patients with coronavirus disease 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective observational study. Demographics, comorbidities, and daily clinical physiologic and laboratory data were collected. Plasma levels of neurofilament-light chain, total tau, ubiquitin carboxy-terminal hydrolase L1, and glial fibrillary acidic protein were measured. The primary neurologic outcome was delirium defined by the Intensive Care Delirium Screening Checklist (scale 1\u20138). Associations among plasma biomarkers, respiratory failure, and inflammation were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Multicenter study in ICUs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Critically ill patients with respiratory failure, with coronavirus disease 2019, or without (ICU control).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>A total of 27 patients with coronavirus disease 2019 and 19 ICU controls were enrolled. Compared with ICU controls with pneumonia of other etiology, patients with coronavirus disease 2019 had significantly higher glial fibrillary acidic protein (272 pg\/mL [150\u2013555 pg\/mL] vs 118 pg\/mL [78.5\u2013168 pg\/mL]; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0009). In coronavirus disease 2019 patients, glial fibrillary acidic protein (rho = 0.5115, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0064), ubiquitin carboxy-terminal hydrolase L1 (rho = 0.4056, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0358), and neurofilament-light chain (rho = 0.6223, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0005) positively correlated with Intensive Care Delirium Screening Checklist score and were increased in patients with delirium (Intensive Care Delirium Screening Checklist \u2265 4) in the coronavirus disease 2019 group but not in ICU controls. There were no associations between the measures of respiratory function or cytokines with glial fibrillary acidic protein, total tau, ubiquitin carboxy-terminal hydrolase L1, or neurofilament-light chain levels in patients with coronavirus disease 2019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Plasma glial fibrillary acidic protein is two-fold higher in critically ill patients with coronavirus disease 2019 compared with ICU controls. Higher levels of glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1, and neurofilament-light chain associate with delirium in patients with coronavirus disease 2019. Elevated plasma glial fibrillary acidic protein, ubiquitin carboxy-terminal hydrolase L1, and neurofilament-light chain are independent of respiratory function and peripheral cytokines.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000238","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T21:19:53Z","timestamp":1601673593000},"page":"e0238","source":"Crossref","is-referenced-by-count":40,"title":["Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019"],"prefix":"10.1097","volume":"2","author":[{"given":"Jennifer","family":"Cooper","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Stukas","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan L.","family":"Hoiland","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada."},{"name":"Centre for Heart, Lung, and Vascular Health, School of Health and Exercise Sciences, Department of Human Kinetics, Faculty of Health and Social Development, University of British Columbia\u2014Okanagan, Kelowna, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Fergusson","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonny","family":"Thiara","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Foster","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Mitra","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Stoessl","sequence":"additional","affiliation":[{"name":"Division of Neurology, Pacific Parkinson\u2019s Research Centre, University of British Columbia, Vancouver, BC, Canada."},{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Panenka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mypinder S.","family":"Sekhon","sequence":"additional","affiliation":[{"name":"Division of Neurology, Pacific Parkinson\u2019s Research Centre, University of British Columbia, Vancouver, BC, Canada."},{"name":"Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Wellington","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Centre for Brain Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada."},{"name":"International Collaboration on Repair Discoveries, Vancouver, BC, Canada."},{"name":"School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"R2-20231023","doi-asserted-by":"crossref","first-page":"117839","DOI":"10.1016\/j.lfs.2020.117839","article-title":"Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review.","volume":"255","author":"Renu","year":"2020","journal-title":"Life Sci"},{"key":"R3-20231023","doi-asserted-by":"crossref","first-page":"116832","DOI":"10.1016\/j.jns.2020.116832","article-title":"Central nervous system manifestations of COVID-19: A systematic review.","volume":"413","author":"Asadi-Pooya","year":"2020","journal-title":"J Neurol Sci"},{"key":"R4-20231023","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China.","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"R5-20231023","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/ene.14329","article-title":"Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.","volume":"27","author":"Vonck","year":"2020","journal-title":"Eur J Neurol"},{"key":"R6-20231023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","article-title":"COVID-19 presenting as stroke.","volume":"87","author":"Avula","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R7-20231023","doi-asserted-by":"crossref","first-page":"E232","DOI":"10.1148\/radiol.2020201697","article-title":"Brain MRI","volume":"297","author":"Kandemirli","year":"2020","journal-title":"Radiology"},{"key":"R8-20231023","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13054-020-02882-x","article-title":"COVID-19: ICU delirium management during SARS-CoV-2 pandemic.","volume":"24","author":"Kotfis","year":"2020","journal-title":"Crit Care"},{"key":"R9-20231023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30062-6","article-title":"Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: A prospective cohort study.","volume":"6","author":"Girard","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R10-20231023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-020-00601-w","article-title":"Relevance of biomarkers across different neurodegenerative diseases.","volume":"12","author":"Ehrenberg","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"R11-20231023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneurol.2016.127","article-title":"Fluid biomarkers for mild traumatic brain injury and related conditions.","volume":"12","author":"Zetterberg","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"R12-20231023","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R13-20231023","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s001340100909","article-title":"Intensive care delirium screening checklist: Evaluation of a new screening tool.","volume":"27","author":"Bergeron","year":"2001","journal-title":"Intensive Care Med"},{"key":"R14-20231023","first-page":"126","article-title":"Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.","volume":"87","author":"Disanto","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R15-20231023","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease.","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"R16-20231023","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker.","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"R17-20231023","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1038\/s41598-019-42351-2","article-title":"Observational study of long-term persistent elevation of neurodegeneration markers after cardiac surgery.","volume":"9","author":"DiMeglio","year":"2019","journal-title":"Sci Rep"},{"key":"R18-20231023","article-title":"Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms.","author":"Zhou","journal-title":"J Neurol"},{"key":"R19-20231023","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/ene.14277","article-title":"Does SARS-Cov-2 invade the brain? Translational lessons from animal models.","volume":"27","author":"Natoli","year":"2020","journal-title":"Eur J Neurol"},{"key":"R20-20231023","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"R21-20231023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2020","journal-title":"Viruses"},{"key":"R22-20231023","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2.","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"R23-20231023","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4037\/ajcc2017263","article-title":"Subsyndromal delirium and institutionalization among patients with critical illness.","volume":"26","author":"Brummel","year":"2017","journal-title":"Am J Crit Care"},{"key":"R24-20231023","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cns.13372","article-title":"Neurological manifestations in COVID-19 caused by SARS-CoV-2.","volume":"26","author":"Baig","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"R25-20231023","article-title":"Elevated interleukin-6 and severe COVID-19: A meta-analysis.","author":"Aziz","journal-title":"J Med Virol"},{"key":"R26-20231023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mcn.2015.02.003","article-title":"Fluid markers of traumatic brain injury.","volume":"66","author":"Zetterberg","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"R27-20231023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders.","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-20231023","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.","volume":"95","author":"Kanberg","year":"2020","journal-title":"Neurology"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T18:24:29Z","timestamp":1698085469000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000238","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}